Onemednet

Onemednet EBITDA per Share

The EBITDA per Share of Onemednet (ONMD) as of Oct 21, 2026 is -0.22 USD. In the previous year, EBITDA per Share was -0.34 USD — a change of -36.77% (higher).

EBITDA per Share

-0.22USD

YoY

-36.77%

Last updated:

EBITDA per Share of Onemednet is 2025 -0.22 USD. EBITDA per Share of Onemednet was 2024 -0.34 USD. It decreases by -36.77% higher compared to the previous year.

The Onemednet EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2020
-0.05 USD
Jan 1, 2021
-0.18 USD
Jan 1, 2022
-0.50 USD
Jan 1, 2023
-0.10 USD
Jan 1, 2024
-0.34 USD
Jan 1, 2025
-0.22 USD
The Onemednet EBITDA per Share history
YEAREBITDA per ShareYoY
-0.22USD-36.77%
-0.34USD+230.49%
-0.10USD-79.25%
-0.50USD+172.70%
-0.18USD+263.14%
-0.05USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Onemednet Stock analysis

What does Onemednet do? Onemednet Corp generates revenue through its OneMedNet iRWD solution, which curates regulatory-grade Imaging Real World Data (RWD) for healthcare providers and life science companies. The company de-identifies and indexes clinical image archives using AI/ML technology, including EHR, radiology, cardiology, lab, and path data, enabling providers to unlock internal and third-party research opportunities. It offers both customized data packages and pre-packaged regulatory-grade imaging RWD sets to meet rigorous life science requirements. Life science companies and healthcare providers are the primary buyers of these data solutions, leveraging the federated network of healthcare providers for research and development purposes. The company's technology allows for advanced search and curation of medical imaging data, supported by in-house clinical expertise. By processing data locally at network sites, OneMedNet iRWD ensures compliance with regulatory standards while providing access to a wealth of internal and third-party research opportunities. Healthcare providers utilize the solution to enhance their data utilization, while life science firms purchase the pre-packaged RWD sets for clinical trials and product development. The solution's focus on AI/ML-driven indexing and regulatory-grade curation differentiates it in the healthcare data market. OneMedNet iRWD serves as a bridge between healthcare providers' internal data archives and life science research needs. The company's approach to de-identifying and curating data locally ensures privacy and compliance, which is critical for regulatory-grade data. Buyers include life science companies requiring RWD for drug development and healthcare providers seeking to monetize their imaging data. The solution's ability to integrate with various clinical data types, such as EHR, radiology, and lab systems, broadens its appeal across multiple healthcare segments. Onemednet is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Onemednet stock

EBITDA per Share of Onemednet is -0.22 USD in 2025.

EBITDA per Share of Onemednet changed from -0.34 USD to -0.22 USD, representing a -36.77% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Onemednet since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Onemednet

All Key Metrics — Onemednet